Navigation Links
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
Date:7/21/2010

SHELTON, Conn., July 21 /PRNewswire/ -- Cara Therapeutics, Inc. announced today that it had closed on a Series D financing of $15 million.  The round was led by new investor, Rho Ventures, with participation from previous investors Alta Biopharma, Ascent Biomedical Ventures, CT Innovations, Devon Park BioVentures, Healthcare Private Equity, Mitsubishi International Corporation and MVM Life Science Partners. In conjunction with the financing, Martin Vogelbaum, a partner at Rho Ventures, will join Cara's Board of Directors. The Series D financing will be used primarily for the continued clinical development of Cara's lead peripherally restricted kappa opioid agonist, CR845, for the treatment of post-operative pain.  Cara has raised more than $43M since inception.

"There has been little innovation in post-operative pain treatment where opioid use continues to be the standard of care even though it is associated with significant side effects which present an ongoing pharmacoeconomic burden for hospitals.  Due to its peripheral activity and lack of CNS penetration, we believe Cara's CR845 has a chance to provide opioid-like pain relief while significantly reducing opioid use and its associated side effects," said Martin Vogelbaum, partner at Rho Ventures.  "We have been impressed with the progress that the Cara team have made to date with CR845 and look forward to working with them as CR845 progresses through the clinic."

"We are very pleased to welcome Rho Ventures as our newest investor and we look forward to benefiting from Martin's considerable experience as we continue the clinical development of CR845," said Derek Chalmers, President and CEO of Cara Ther
'/>"/>

SOURCE Cara Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... and DRESDEN, Germany , ... BioScience, a leading preclinical contract research provider and ... content-driven pharmacology, and Debiopharm Group™ (Debiopharm), a Swiss-based ... on the development of prescription drugs that target ... today announced that they have signed a research ...
(Date:5/22/2013)... 22, 2013  Aribex, Inc., manufacturer of the newly ... a new color option, black with gray trim, of ... veterinary markets. The popular white with light blue trim ... to be available and both models can be purchased ... (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are ...
(Date:5/22/2013)... 22, 2013 Advanced Prenatal Therapeutics (APT), a ... will help alleviate the high blood pressure and other ... expected to be the first medical device specifically designed ... fetal death. Every year, preeclampsia affects approximately ... . It is characterized by high blood pressure ...
Breaking Medicine Technology:Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4Aribex Unveils New Color of NOMAD Pro 2 2Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
... March 2, 2011 InspireMD ... system , has expanded its MGuard production facilities to ... behind the accelerating demand for MGuard include the recent ... protection to be considered for PCI of highly thrombotic ...
... 2011 Accumetrics, Inc., a privately-held developer and marketer ... point-of-care diagnostic system for measuring platelet reactivity to multiple ... an agreement with Portola Pharmaceuticals, Inc. to develop and ... clinical trials. The VerifyNow System is widely ...
Cached Medicine Technology:InspireMD Boosts MGuard Production Capacity 2Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc. 2
(Date:5/23/2013)... (PRWEB) May 23, 2013 With crowded ... more popular. But according to Mike Whitfield, a bodyweight ... of equipment like the medicine ball can add a ... Whitfield runs BodyweightTorch.com, a website in which anyone can ... uses no equipment. Recently, he shared a video with ...
(Date:5/23/2013)... Studies show that kids and teens who ... less likely to be overweight, less likely to engage in ... have better relationships with their parents. , Despite ... family dinner expert and advocate Aviva Goldfarb . Over ... percent. When families do eat together, average mealtimes last a ...
(Date:5/23/2013)... May 23, 2013 Dr. Garber's ... condition specific remedies are now available at Whole Foods ... CA 92677. The line of natural biotherapy formulas continues ... Chain. , Represented by Brandstorm HBC (Los Angeles, CA), ... Markets throughout California, Nevada and Arizona, as well as ...
(Date:5/23/2013)... Brad Schmett, Broker Associate with Luxury Homes ... Palm Springs area real estate market will ... of the Annual Memorial Day Flower Drop at the ... , Culminating the festive three-day weekend, Valley residents will ... with flight exhibitions. However, the highlight of the Memorial ...
(Date:5/23/2013)... 23, 2013 To help members ... Walkingspree is pleased to announce integration of its ... devices. This new upgrade automatically transfers real-time step ... to track their company’s team standings, view progress ... fat burned. , Walkingspree also offers an integrated ...
Breaking Medicine News(10 mins):Health News:Unique Ab Exercise, the Medicine Ball Chop, Released from BodyweightTorch.com 2Health News:Family Dinner Expert and Cookbook Author Announces “Family Dinner Challenge” 2Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2Health News:Annual Memorial Day Flower Drop Honors Veterans in Palm Springs California by Brad Schmett 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 3
... special clinic on wheels is being launched for sex ... treatment for sexually transmitted// disease along with blood test ... mobile clinic that would provide blood test facilities, treatment ... of sex workers for free is being launched here ...
... Indonesia's Bogor Institute of Agriculture have announced a joint ... for animals. The company to be called IPB Shigeta ... vaccine in a very short time. ,U.S.-based ... company to use its patented reverse genetics technology to ...
... friendly 7-year-old at Shaughnessy Elementary School died on Tuesday due ... had fever and headache and was sent home by the ... up and she did not budge she was taken to ... pronounced dead. She is the first child under 12 to ...
... even after eight days//. Now resident doctors from hospitals have ... in the city. ,Resident doctors in lab coats, ... to appeal to the public. Doctors from JJ hospital, KEM ... Mumbaikars on their way to work. ,The Doctor ...
... Hospitals trust is going to cut off nearly 300 jobs ... funding formula that incurred huge losses. //Royal Cornwall Hospitals Trust ... debts of ?8.1 million which might force it to ... ,Market Forces Factor (MFF) has perhaps caused this downslide, ...
... Institute for Health Information (CIHI) said that despite the ... been no shortening of waiting time. // Glenda Yeates, ... of diagnostic tests and high-priority procedures has increased dramatically. ... increased just as much. Statistics show that the number ...
Cached Medicine News:Health News:Mobile Clinic For Sex Workers In Pune 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: